Search results

1 – 10 of over 1000
Per page
102050
Citations:
Loading...
Available. Content available
Book part
Publication date: 14 September 2020

Eva Tutchell and John Edmonds

Free Access. Free Access

Abstract

Details

Unsafe Spaces
Type: Book
ISBN: 978-1-78973-062-3

Access Restricted. View access options
Article
Publication date: 1 August 1994

Peter Dunn

Quality assurance and associated activities play an increasinglyimportant role in industry today. Aims to remind the academic of theneed to understand fully and consider…

162

Abstract

Quality assurance and associated activities play an increasingly important role in industry today. Aims to remind the academic of the need to understand fully and consider industrial sectors which operate in environments where computers and paper have no part to play.

Details

The TQM Magazine, vol. 6 no. 4
Type: Research Article
ISSN: 0954-478X

Keywords

Access Restricted. View access options
Book part
Publication date: 14 September 2020

Eva Tutchell and John Edmonds

Abstract

Details

Unsafe Spaces
Type: Book
ISBN: 978-1-78973-062-3

Access Restricted. View access options
Article
Publication date: 3 July 2017

Vesela Veleva and Berkeley W. Cue Jr

The purpose of this paper is to benchmark current adoption of green chemistry (GC) practices by the innovative and generic pharmaceutical companies and examine the drivers…

1167

Abstract

Purpose

The purpose of this paper is to benchmark current adoption of green chemistry (GC) practices by the innovative and generic pharmaceutical companies and examine the drivers, barriers and future opportunities.

Design/methodology/approach

The authors examined publicly available data for the top 10 “big pharma” and top ten generic drug manufacturers. Using the IQ Green Chemistry working group framework for effective GC programs, they scored each of the 20 companies in seven key areas.

Findings

The study finds that generic drug companies have not embraced GC at the level of the innovative pharmaceutical companies (average GC score of 2 vs 11 for “big pharma”). Top two barriers for them include: lack of pressure and incentives, and the burdensome regulatory process for making changes in the manufacturing process.

Research limitations/implications

The research is based on publicly disclosed information. It is possible that some generic drug manufacturers have begun to work internally on GC but have not disclosed externally yet. Future research should include a survey or interviews of generic drug manufacturers.

Practical implications

The company-level analysis, benchmarking framework and results are of value for researchers and practitioners interested in advancing greater adoption of GC by the pharmaceutical industry.

Originality/value

This study provides the first company-level benchmarking of GC adoption by the largest innovative and generics drug manufacturers. It contributes to the literature on the barriers and drivers for greater adoption of GC.

Details

Benchmarking: An International Journal, vol. 24 no. 5
Type: Research Article
ISSN: 1463-5771

Keywords

Access Restricted. View access options
Article
Publication date: 27 April 2012

Brian Leavy

The purpose of this paper is to present an interview with Professor Michael Beer of Harvard Business School, whose recent book is Higher Ambition: How Great Leaders Create

1758

Abstract

Purpose

The purpose of this paper is to present an interview with Professor Michael Beer of Harvard Business School, whose recent book is Higher Ambition: How Great Leaders Create Economic and Social Value, to learn what methods these leaders use.

Design/methodology/approach

The paper discusses his book, in whihc Beer and his co‐authors studied 36 corporate leaders who are recognized for inspiring their firms to create superior and lasting economic and social value. Beer calls this “higher ambition” management and says it is the key to transforming companies into high commitment, high performance organizations.

Findings

Beer and his co‐authors found evidence that creating social value unlocks the dormant creative energies that exist in all employees. Creating both social and economic value directly reinforces the primary motivators of people, purpose, autonomy and mastery.

Research limitations/implications

The authors did not systematically investigate leaders and companies who did not fit the higher ambition (HA) definition. Thus it is impossible to conclude definitively that the HA practices described in the book are distinctive – that they do not also exist in companies that do not fit the HA definition. The authors did, however, use their consulting experience with many companies over many years and interviews with a few CEOs who were not HA leaders to contrast HA leadership practices with “common” and “best practice.”

Practical implications

Beer's advice for rising executives aspiring to become higher‐ambition leaders: find your anchor, choose your teachers and company, learn from experience, and engage in honest conversations.

Originality/value

Beer explains why a leader's higher ambition is essential to creating a resilient and sustainable enterprise and how top CEOs do it.

Available. Content available
Article
Publication date: 1 September 2006

102

Abstract

Details

Industrial Robot: An International Journal, vol. 33 no. 5
Type: Research Article
ISSN: 0143-991X

Keywords

Access Restricted. View access options
Article
Publication date: 1 December 1996

26

Abstract

Details

Mental Health Review Journal, vol. 1 no. 4
Type: Research Article
ISSN: 1361-9322

Access Restricted. View access options
Article
Publication date: 1 December 1996

24

Abstract

Details

Mental Health Review Journal, vol. 1 no. 4
Type: Research Article
ISSN: 1361-9322

Access Restricted. View access options
Article
Publication date: 1 December 1996

26

Abstract

Details

Mental Health Review Journal, vol. 1 no. 4
Type: Research Article
ISSN: 1361-9322

Available. Content available

Abstract

Details

Strategy & Leadership, vol. 40 no. 4
Type: Research Article
ISSN: 1087-8572

1 – 10 of over 1000
Per page
102050